Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions

Completed

Conditions studied: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma

In brief

This laboratory study is looking at genes in participants with neuroblastoma or noncancerous conditions. Identifying genes related to cancer may help in the study of cancer. It may also help doctors predict who is at risk of developing neuroblastoma.

Key facts

Study ID

NCT00436696

Run by

Children's Oncology Group

People needed

9350

Starts

2006-12-11

Last updated by the study team

2018-08-07

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patient:
• Diagnosis of neuroblastoma
• Banked constitutional and genomic DNA within COG-ANBL00B1 Neuroblastoma Biology protocol or another COG Biology Protocol
• At least 1.0 ?g of DNA available
• Control (age, race, and gender-matched):
• No diagnosis of cancer
• May have other conditions, including any of the following:
• Asthma
• Inflammatory bowel disease
• Attention-deficit disorder
• Obesity

Where it is running

• University of Mississippi Medical Center — Jackson, Mississippi, United States
• Childrens Oncology Group — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.